Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) announced that it has received the Drug Registration Certificate for Lidocaine and Prilocaine Cream issued by the National Medical Products Administration. The cream is a compound preparation of lidocaine and prilocaine, intended for topical skin anesthesia in the following scenarios: needle punctures (e.g., catheter insertion or blood collection), superficial surgical procedures (e.g., genital mucosa prior to superficial surgery or infiltration anesthesia), and leg ulcer cleaning/debridement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments